NCT06316401Completed
Endoscopic Submucosal Dissection of Large Recto-sigmoid Lesions Under Spinal Anesthesia
Source: ClinicalTrials.gov · Last updated 18 Mar 2024
Brief summary (registry, in English)
The investigators collected data on all consecutive patients who underwent ESD for recto-sigmoid laterally spreading tumors (LSTs) \>35 mm under SA between January 2021 and March 2024. The investigators evaluated the technical success and safety of SA in terms of ARAEs, and pain, measured via visual assessment scale (VAS).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 20 (actual)
- First submitted
- 5 Mar 2024
- Start date
- 1 Jan 2021
- Primary completion date
- 31 Jan 2023
- Lead sponsor
- Azienda USL Modena
- Diseases
- Colorectal cancer
- NCT number
- NCT06316401
What you commit to
- Study type: Observational
- Participants enrolled: 20
- From 1 Jan 2021 to the primary completion date, 31 Jan 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- allergy to medications used for spinal anesthesia
Age
- age \<18 years
Other
- ASA score V
- pregnancy
- breastfeeding
Who the study is looking for
- age ≥18 years
- American Society of Anaesthesiologists (ASA) score I-IV
- ability to give informed consent
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mauro Manno Coordinator of this site? Confirm its status | Carpi | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.